Abstract:Aβ is a product derived from sequential proteolytic cleavage of β–amyloid precursor protein (APP) by β–and γ–secretases, while cleavage of APP by α–and γ–secretases does not yield Aβ. Since β–and γ–secretases are located in cholesterol–rich lipid rafts of cell membrane and α–secretase is located in phospholipid–rich domains of cell membrane, the activities of these secretases and APP processing may be subject to the changes of cholesterol or/and phospholipids in cellular membrane. A group of ATP–binding cassette (ABC) transporters are known to transport and regulate cholesterol and phospholipids in cells, such as ABCA1, ABCG1 and ABCG4. These transporters can mediate efflux of cholesterol and phospholipids from cell membrane to high–density lipoproteins (HDL). ABCG1 and ABCG4 are primarily expressed in the brain and can form homodimer or heterodimer to function. We have studied the roles of ABCG1/ABCG4 and cholesterol in the regulation of β–and γ–secretase activities for Aβ production and demonstrated that: 1) Cholesterol assays revealed that the level of cholesterol was significantly higher in AD than in age–matched non–demented (ND) control brain samples. 2) In vitro assays demonstrated that the activities of β–and γ–secretases were significantly higher in AD than in ND brain samples, which correspond to higher levels of cholesterol and Aβ deposition in AD brain samples. 3) ABCG1 and ABCG4 are highly expressed in normal human brain samples. However, real–time Q–PCR and Western blots showed that ABCG1 and ABCG4 were down–regulated at the protein and mRNA levels, respectively, in AD compared to ND brain samples. 4) Human ABCG1 and ABCG4 genes were cloned and their overexpression in neuroblastoma N2a cells–transfected with APP increased cellular cholesterol efflux to HDL by cholesterol efflux assays and significantly decreased cellular cholesterol levels compared to empty vector–transfected cells. 5) Reduced cellular cholesterol mediated by ABCG1/ABCG4 efflux significantly decreased β–and γ–secretase activities and Aβ production in N2a cells. These results suggest that higher cholesterol levels correlate well with higher β–and γ–secretase activities and Aβ deposition in AD compared to ND brain samples and that ABCG1/ABCG4–mediated cholesterol efflux to HDL is an important factor affecting cellular cholesterol that regulates β–and γ–secretase activities for Aβ production.

ApoE and ABCG2 expression

P4–057: ABCG1/ABCG4–mediated Cellular Cholesterol Efflux Affects Β–and Γ–secretase Activities and Β–amyloid Production in N2a Cells

Effect of Apolipoprotein E isoforms on the Abundance and Function of P-glycoprotein in Human Brain Microvascular Endothelial Cells

C/EBPβ is a key transcription factor for APOE and preferentially mediates ApoE4 expression in Alzheimer’s disease

Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice

C/EBPβ/AEP Signaling Activated by ApoE4 and 27-Hydroxycholesterol in Macrophages Mediates Cerebral Amyloid Angiopathies in Alzheimer’s Disease

iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta

ApoE3 vs. ApoE4 Astrocytes: A Detailed Analysis Provides New Insights into Differences in Cholesterol Homeostasis

Binding and repressive activities of apolipoprotein E3 and E4 isoforms on the human ApoD promoter

Effects of human apolipoprotein E isoforms on the amyloid β‐protein concentration and lipid composition in brain low‐density membrane domains

APOE Genotype Alters Immunoglobulin Subtypes in Knock-In Mice

ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy

Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer's disease biomarkers

The effects of ABCA1 on cholesterol efflux and Abeta levels in vitro and in vivo

P4-402 Alzheimer's Disease Drug Discovery Targeted to the APP MRNA 5′ Untranslated Region, a Validated Target

Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease

Behavioral and Metabolic Effects of ABCG4 KO in the APPswe,Ind (J9) Mouse Model of Alzheimer's Disease

Targeting of Nonlipidated, Aggregated Apoe with Antibodies Inhibits Amyloid Accumulation

Expression of Apolipoprotein E in Alzheimer's Disease and Its Significance

AÃÂ² Metabolism and the Role of APOE in AlzheimerÃ¢ÂÂs Disease

The Specific Impact of Apolipoprotein E Epsilon 2 on Cognition and Brain Function in Cognitively Normal Elders and Mild Cognitive Impairment Patients